| 齐拉西酮治疗精神分裂症的疗效评价 |
| |
| 引用本文： | 何磊英. 齐拉西酮治疗精神分裂症的疗效评价[J]. 世界临床药物, 2014, 0(9): 570-574 |
| |
| 作者姓名： | 何磊英 |
| |
| 作者单位： | 上海市金山区精神卫生中心,上海201515 |
| |
| 摘 要： | 精神分裂症是一组病因未明的精神疾病,具有思维、情感、认知行为等多方面障碍及精神活动不协调。长程治疗可大大减少精神分裂症的复发,齐拉西酮作为一种新型抗精神分裂症药物,近两年在临床的应用越来越广泛。本文综述近年来齐拉西酮用于精神分裂症治疗的疗效研究。
|
| 关 键 词： | 齐拉西酮 精神分裂症 治疗 |
Efficacy evaluation of ziprasidone for treatment in schizophrenia |
| |
| HE Lei-ying. Efficacy evaluation of ziprasidone for treatment in schizophrenia[J]. WORLD CLINICAL DRUGS, 2014, 0(9): 570-574 |
| |
| Authors: | HE Lei-ying |
| |
| Affiliation: | HE Lei-ying (Mental Health Center of Shanghai Jinshan District, Shanghai 201515, China) |
| |
| Abstract: | Schizophrenia is a serious, complex and debilitating mental illness. The illness displays a widely variable symptom profile, with positive, negative or depressive symptoms and cognitive deficits. Long-term treatment is necessary to decrease the risk of relapse. As a new antipsychotic drug, ziprasidone is used more and more extensively in clinical application in these years. This review describes the development of ziprasidone for schizoohrenia treatment in clinic, |
| |
| Keywords: | ziprasidone schizophrenia clinical therapy |
| 本文献已被 维普 等数据库收录！ |
|
